Esmirtazapine
id:
esmirtazapine-253-9208361
title:
Esmirtazapine
text:
Esmirtazapine (ORG-50,081) is a tetracyclic antidepressant drug that was under development by Organon for the treatment of insomnia and vasomotor symptoms (e.g., hot flashes) associated with menopause. Esmirtazapine is the (S)-(+)-enantiomer of mirtazapine and possesses similar overall pharmacology, including inverse agonist actions at H1 and 5-HT2 receptors and antagonist actions at α2-adrenergic receptors. Notably, esmirtazapine has a shorter half life of around 10 hours, compared to R-mirtaza
brand slug:
wiki
category slug:
encyclopedia
description:
Drug formerly under development for treatment of menopause symptoms
original url:
https://en.wikipedia.org/wiki/Esmirtazapine
date created:
date modified:
2024-02-29T14:56:27Z
main entity:
{"identifier":"Q3058085","url":"https://www.wikidata.org/entity/Q3058085"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/4/48/Esmirtazapine_2D_structure.svg","width":341,"height":306}
fields total:
13
integrity:
15